1. | Oki, S, and S. Miyake: Invariant Natural Killer T (iNKT) cells in asthma: A novel insight into the pathogenesis of asthma and the therapeutic implication of glycolipid ligands for allergic diseases. Allergol Int 56:7-14, 2007 |
2. | Kuroda, R, J-i. Satoh, T. Yamamura, T. Anezaki, T. Terada, K. Yamazaki, T. Obi, and K. Mizoguchi: A novel compound heterozygous mutation in the DAP12 gene in a patient with Nasu-Hakola disease. J Neurol Sci 252:88-91, 2007 |
3. | Satoh, J-i, H. Tabunoki, T. Yamamura, K. Arima, and H. Konno: TROY and LINGO-1 expression in astrocytes and macrophages/microglia in MS brains. Neuropathol and Applied Neurobiol 33:99-107, 2007 |
4. | Onoue, H, J-i. Satoh, M. Ogawa, and T. Yamamura : Detection of anti-Nogo receptor autoantibody in the serum of multiple sclerosis and controls. Acta Neurologica Scandin 115:153-160, 2007 |
5. | Maresz, K, G. Pryce, E. D. Ponomarev, G. Marsicano, J. L. Croxford, L.P. Shriver, C. Ledent, X. Cheng, E. Carrier, M.K. Mann, G. Giovannoni, R. G. Pertwee, T. Yamamura, N.E. Buckley, C.J. Hillard, B. Lutz, D. Baker and B. N. Dittel: Direct Suppression of CNS Autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat Med 13:492-497, 2007 |
6. | Toba, T, K. Murata, K. Nakanishi, B. Takahashi, N. Takemoto, M. Akabane, T. Nakatsuka, S. Imajo, T. Yamamura, S. Miyake, and H. Annoura: Minimum structure requirement of immunomodulatory glycolipids for predominant Th2 cytokine induction and the discovery of non-linear phytosphingosine analogs. Bioorganic & Medicinal Chemistry Letters 17:278-2784, 2007 |
7. | Miyake S, and T. Yamamura: Therapeutic potential of CD1d-restricted invariant natural killer T cell-based treatment for autoimmune diseases. Int Rev Immunol 26:73-94, 2007 |
8. | Yamamura, T.: Interleukin 17-producing T-helper cells and autoimmune diseases: Time for a paradigm shift? Current Rheumatology Reports 9:93-95, 2007 |
9. | Kaieda, S, S. Oki, C. Tomi, T. Yamamura and S. Miyake: Activation of invariant natural killer T cells by synthetic glycolipid ligands suppresses autoantibody-induced arthritis. Arthr Rheumat 56:1836-1845, 2007 |
10. | Sato, W, T. Aranami, and T. Yamamura: Cutting Edge. Human Th17 cells are identified as bearing CCR2+CCR5-phenotype. J Immunol 178:7525-7529, 2007 |
11. | Miyake, S. and T. Yamamura: NKT cells and autoimmune diseases: Unraveling the complexity. In T cell activation by CD1 and lipid antigens. (Edited by Branch D. Moody; Springer-Verlag), Current Topics in Microbiology and Immunology 314:251-265, 2007 |
12. | Satoh, J-i, H. Tabunoki, T. Yamamura, K. Arima, and H. Konno: Human astrocytes express aquaporin-1 and aquaporin-4 in vitro and in vivo. Neuropathology 27: 245-256, 2007 |
13. | Satoh, J, Z. Illes, A. Peterfalvi, H. Tabunoki, C. Rozsa, and T. Yamamura: Aberrant transcriptional regulatory network in T cells of multiple sclerosis. Neurosci Lett 422: 30-33, 2007 |
14. | Sakuishi, K, S. Oki, M. Araki, S.A. Porcelli, S. Miyake, and T. Yamamura: Invariant NKT cells biased for IL-5 production act as crucial regulators of inflammation. J Immunol 179:3452-3462, 2007 |
15. | Yamamura, T, K. Sakuishi, Zs. Illes, and S. Miyake: Understanding the behavior of invariant NKT cells in autoimmune diseases. J. Neuroimmunol. 191:8-15, 2007 |
16. | Ambosino, E, M. Terabe, R.C. Halder, J. Peng, S. Takaku, S. Miyake, T. Yamamura, V. Kumar, and J.A. Berzofsky: Cross-regulation between type I and type II NKT cells in regulating tumor immunity: A new immunoregulatory axis. J Immunol 179:5126-5136, 2007 |
17. | Sekine, C, T. Sugihara, S. Miyake, H. Hirai, M. Yoshida, N. Miyasaka, and H. Kohsaka. Successful treatment of animal models of rheumatoid arthritis with small-molecule cyclin-dependent kinase inhibitors. J Immunol 180:1954-1961, 2008 |
18. | Croxford, J.L, G. Pryce, S.M. Jackson, C. Ledent, G. Giovannoni, R.G. Pertwee, T. Yamamura, and D. Baker: Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis. J Neuroimmunol 193: 120-129, 2008 |
19. | Dondji, B, E. Deak, K. Goldsmith-Pestana, E. Perez-Jimenez, M. Esteban, S. Miyake, T. Yamamura and D. McMahon-Pratt. Intradermal activation of NKTi cells during DNA priming in heterologous prime-boost vaccination enhances effector and memory T cell responses and protection against Leishmania major infection. Eur J Immunol 38:706-719, 2008 |
20. | Satoh, J-i, S. Obayashi, T. Misawa, H. Tabunoki, T. Yamamura, K. Arima, and H. Konno: Neuromyelitis optica/Devic's disease: Gene expression profiling of brain lesions. Neuropathology 28: 561-576, 2008 |
21. | Aranami, T. and T. Yamamura: Th17 cells and autoimmune encephalomyelitis (EAE/MS). Allergol. Int. 57 115-120, 2008 |
22. | Doi, Y, S. Oki, T. Ozawa, H. Hohjoh, S. Miyake, and T. Yamamura: Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines. Proc Natl Acad Sci U S A 105: 8381-8386, 2008 |
23. | Okamoto, T, M. Ogawa, Y. Lin, M. Murata, S. Miyake, and T. Yamamura: Treatment of Neuromyelitis Optica: Current Debate. Therapeutic Advances in Neurological Disorders. 1: 43-52, 2008 |
24. | IIjima, M, H. Koike, N. Hattori, A. Tamakoshi, M. Katsuno, F. Tanaka, M. Yamamoto, K. Aimura, G. Sobue and Refractory Peripheral Neuropathy Study Group of Japan (Including T. Yamamura). Prevalance and incidence rates of chronic inflammatory demyelinating polyneuropathy in the Japanese population. J Neurol Neurosurg Psychiatry 79: 1040-1043, 2008 |
25. | Satoh, J-i, T. Misawa, H. Tabunoki, and T. Yamamura: Molecular network analysis of T-cell transcriptome suggests aberrant regulation of gene expression by NF-κB as a biomarker for relapse of multiple sclerosis. Dis Markers 25: 27-35, 2008 |
26. | Shimamura, M, Y-Y. Huang, R. Migishima, M. Yokoyama, T. Saitoh, and T. Yamamura: Localization of NK1.1+ invariant Vα19 TCR+ cells in the liver with potential to promptly respond to TCR stimulation. Immunol Lett 121: 38-44, 2008 |
27. | Araki, M, S. Miyake, and T. Yamamura: Synthetic glycolipid ligands for human iNKT cells as potential therapeutic agents for immunotherapy. Curr Medicinal Chem 15: 2337-2345, 2008 |
28. | Yokote, H, S. Miyake, J.L. Croxford, S. Oki, H. Mizusawa, and T. Yamamura: NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. Am J Pathol 173: 1714-1723, 2008 |
29. | Osoegawa, M, J. Kira, T. Fukazawa, K. Fujihara, S. Kikuchi, M. Matsui, T. Kohriyama, G. Sobue, T. Yamamura, Y. Itoyama, T. Saida, K. Sakata, H. Ochi, and T. Matsuoka: The research Committee of Neuroimmunologic Diseases. Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler 15:159-173, 2009 |
30. | Ishizu, T, JI. Kira, M. Osoegawa, T. Fukazawa, S. Kikuchi, K. Fujihara, M. Matsui, T. Kohriyama, G. Sobue, T. Yamamura, Itoyama Y, Saida T, Sakata K; The Research Committee of Neuroimmunological Diseases: Heterogeneity and continuum of multiple sclerosis phenotypes in Japanese according to the results of the fourth nationwide survey. J Neurol Sci 80:22-28, 2009 |
31. | Satoh, J.I, H. Tabunoki, and T. Yamamura: Molecular network of the comprehensive multiple sclerosis brain lesion proteome. Mult Scler 15:531-541, 2009 |
32. | Klemann, C, B.J.E. Raveney, A.K. Klemann, T. Ozawa, S. von Hoersten, K. Shudo, S. Oki and T. Yamamura: Synthetic retinoid AM80 inhibits Th17 cells and ameliorates EAE. Am J Pathol 174: 2234-2245, 2009 |
33. | Croxford, J.L, and T. Yamamura: Back to the future for multiple sclerosis therapy: Focus on current and emerging disease-modifying therapeutic strategies. Immunotherapy 1: 403-424, 2009 |
34. | Theil, M.M, S. Miyake, M. Mizuno, C. Tomi, J.L. Croxford, H. Hosoda, J. Theil, S. von Hoersten, H. Yokote, A. Chiba, Y. Lin, S. Oki, T. Akamizu, K. Kangawa, and T. Yamamura: Suppression of experimental autoimmune encephalomyelitis by Ghrelin. J Immunol 183: 2859-2866, 2009 |
35. | Fujita, M, T. Otsuka, M. Mizuno, C. Tomi, T.M. Gallagher, T. Yamamura, and S. Miyake: Carcinoembryonic antigen-related cell adhesion molecule 1 modulates experimental autoimmune encephalomyelitis via iNKT cell-dependent mechanism. Am J Pathol 175: 1163-1123, 2009 |
36. | Miyake, S, and T. Yamamura: Ghrelin: friend of foe for neuroinflammation. Discov Med 8: 64-67, 2009 |